149 related articles for article (PubMed ID: 5020976)
1. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
[No Abstract] [Full Text] [Related]
2. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
[TBL] [Abstract][Full Text] [Related]
3. Use of the macrophage migration inhibition test to evaluate antigenic differences in golden hamster transplantable melanomas.
Kozłowska K; Zurawska-Czupa B; Mierzewski P; Kostulak A
Int J Cancer; 1980 Aug; 26(2):211-5. PubMed ID: 6162805
[TBL] [Abstract][Full Text] [Related]
4. The specificity of cellular immune reactions to three DNA virus induced tumours, as measured by the macrophage migration inhibition test.
Rees RC; Potter CW; Shelton J
Eur J Cancer (1965); 1975 Feb; 11(2):79-86. PubMed ID: 48461
[No Abstract] [Full Text] [Related]
5. Studies on antigenicity and immunogenicity of transplantable melanoma in hamster by using migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):445-7. PubMed ID: 749795
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific cellular immunity.
Cohen AM; Burdick JF; Ketcham AS
J Surg Res; 1971 Aug; 11(8):421-31. PubMed ID: 4936302
[No Abstract] [Full Text] [Related]
8. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
9. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
10. A model for immunity to melanomas in mice.
Burger DR; Hu F; Pasztor LM; Malley A
Proc Soc Exp Biol Med; 1973 Nov; 144(2):426-30. PubMed ID: 4746912
[No Abstract] [Full Text] [Related]
11. Immunologic mechanisms in malignant melanoma of the skin.
Cochran AJ
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
[No Abstract] [Full Text] [Related]
12. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
13. Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.
Churchill WH; Zbar B; Belli JA; David JR
J Natl Cancer Inst; 1972 Feb; 48(2):541-9. PubMed ID: 4119886
[No Abstract] [Full Text] [Related]
14. Blocking of a cellular immune reaction to malignant melanoma by immunoglobulin from tumor-bearing animals.
Henderson WR; Fukuyama K; Epstein WL; Spitler LE
J Reticuloendothel Soc; 1973 Feb; 13(2):155-60. PubMed ID: 4705738
[No Abstract] [Full Text] [Related]
15. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
Svoboda I; Măzuran R; Rabatić S; Silobrcić
Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
[TBL] [Abstract][Full Text] [Related]
16. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
17. Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens.
Meltzer MS; Oppenheim JJ; Littman BH; Leonard EJ; Rapp HJ
J Natl Cancer Inst; 1972 Sep; 49(3):727-34. PubMed ID: 4345967
[No Abstract] [Full Text] [Related]
18. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
19. [Interaction between cellular and serum factors of immunity in the dynamics of chemical carcinogenesis].
Maĭskiĭ IN; Aĭrapet'ian GP; Gudkova RB; Krylova LD
Biull Eksp Biol Med; 1974 Nov; 78(11):86-9. PubMed ID: 4614879
[No Abstract] [Full Text] [Related]
20. [Cellular immunity in melanomalignome (author's transl)].
Fritz J; Grond K; Tilz GP
Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
